Meta-analysis of randomized clinical trials comparing PCSK9 monoclonal antibody versus ezetimibe/placebo in patients at high cardiovascular risk
Wenfang Ma, Xiying Guo, Yiming Ma, Zhao Hu
Topics & Concepts
EzetimibePCSK9MedicinePlaceboInternal medicineMyocardial infarctionRelative riskStroke (engine)GastroenterologyRandomized controlled trialAdverse effectCholesterolLipoproteinLDL receptorConfidence intervalPathologyMechanical engineeringEngineeringAlternative medicineLipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular DiseasesCholesterol and Lipid Metabolism